BARICITINIB vs TOFACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BARICITINIB vs TOFACITINIB: Safety Overview
| Metric | BARICITINIB | TOFACITINIB |
|---|---|---|
| Total FAERS Reports | 8,108 | 155,647 |
| Deaths Reported | 717 | 7,847 |
| Death Rate | 8.8% | 5.0% |
| Hospitalizations | 2,498 | 21,976 |
| Average Patient Age | 58.2 yrs | 57.6 yrs |
| % Female Patients | 67.9% | 81.6% |
| FDA Approval Date | Aug 8, 2025 | Aug 19, 2021 |
| Manufacturer | Eli Lilly and Company | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |